Standard name |
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP |
Systematic name |
M9811 |
Brief description |
Genes up-regulated in 293 cells (embryonic kidney) expressing polymorphic variants S427G (SNP ID=rs2070235) or I624M (SNP ID=rs11556379) of BMYB [GeneID=4605]. |
Full description or abstract |
The B-MYB proto-oncogene is a transcription factor belonging to the MYB family that is frequently overexpressed or amplified in different types of human malignancies. While it is suspected that B-MYB plays a role in human cancer, there is still no direct evidence of its causative role. Looking for mutations of the B-MYB gene in human cell lines and primary cancer samples, we frequently isolated two nonsynonymous B-MYB polymorphic variants (rs2070235 and rs11556379). Compared to the wild-type protein, the B-MYB isoforms display altered conformation, impaired regulation of target genes and decreased antiapoptotic activity, suggesting that they are hypomorphic variants of the major allele. Importantly, the B-MYB polymorphisms are common; rs2070235 and rs11556379 are found, depending on the ethnic background, in 10-50% of human subjects. We postulated that, if B-MYB activity is important for transformation, the presence of common, hypomorphic variants might modify cancer risk. Indeed, the B-MYB polymorphisms are underrepresented in 419 cancer patients compared to 230 controls (odds ratio 0.53; (95%) confidence interval 0.385-0.755; P=0.001). This data imply that a large fraction of the human population is carrier of B-MYB alleles that might be associated with a reduced risk of developing neoplastic disease. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 18026132 Authors: Schwab R,Bussolari R,Corvetta D,Chayka O,Santilli G,Kwok JM,Ferrari-Amorotti G,Tonini GP,Iacoviello L,Bertorelle R,Menin C,Hubank M,Calabretta B,Sala A |
Exact source |
Table 2S: WT to ATG |
Related gene sets |
(show 1 additional gene sets from the source publication)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Jessica Robertson (MSigDB Team) |
Source platform or identifier namespace |
AFFY_HG_U133 |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 13 genes
|
Gene families ? |
Categorize these
13 genes by gene family
|
Show members |
(show 15 source identifiers mapped to 13 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
202426_s_at |
6256 |
RXRA |
retinoid X receptor alpha [Source:HGNC S... |
204696_s_at |
993 |
CDC25A |
cell division cycle 25A [Source:HGNC Sym... |
205386_s_at |
4193 |
MDM2 |
MDM2 proto-oncogene [Source:HGNC Symbol;... |
208218_s_at |
91 |
ACVR1B |
activin A receptor type 1B [Source:HGNC ... |
208415_x_at |
3621 |
ING1 |
inhibitor of growth family member 1 [Sou... |
208711_s_at |
595 |
CCND1 |
cyclin D1 [Source:HGNC Symbol;Acc:HGNC:1... |
209172_s_at |
1063 |
CENPF |
centromere protein F [Source:HGNC Symbol... |
210556_at |
4775 |
NFATC3 |
nuclear factor of activated T cells 3 [S... |
211792_s_at |
1031 |
CDKN2C |
cyclin dependent kinase inhibitor 2C [So... |
213920_at |
23316 |
CUX2 |
cut like homeobox 2 [Source:HGNC Symbol;... |
215997_s_at |
8450 |
CUL4B |
cullin 4B [Source:HGNC Symbol;Acc:HGNC:2... |
216002_at |
|
|
|
220691_at |
|
|
|
221789_x_at |
89941 |
RHOT2 |
ras homolog family member T2 [Source:HGN... |
222123_s_at |
64344 |
HIF3A |
hypoxia inducible factor 3 subunit alpha... |
|
Version history |
3.1: SCHWAB_TARGETS_OF_BMYB_S427G_UP
|